Australian-led global study redefines treatment pathway for high-risk prostate cancer
New research findings from the ENZARAD study (ANZUP 1303), led by the Australian and New…
Browsing: ANZUP
ANZUP Cancer Trials Group Wraps Up Successful 2023 ASM
The Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group recently held another…
ASCO 2022: Three-year follow up results from the TheraP study for metastatic prostate cancer
The Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) reports the three-year…
ASCO 2022: The updated results from the ENZAMET clinical trial
The Australian-led clinical trial ENZAMET has shown that the addition of hormone therapy with a…
First patient enrolled in new world-first study into prostate cancer
The first of a planned 100 patients has been enrolled on a new cancer trial…
International Clinical Trials Day 2022 – Interview with Dr. Ciara Conduit
Friday, May 20 is International Clinical Trials Day, a day that highlights the importance of…
International Clinical Trials Day 2022 – Interview with Professor Dickon Hayne
Friday, May 20 is International Clinical Trials Day, a day that highlights the importance of…
ANZUP ASM 2021 review
The 2021 ANZUP Annual Scientific Meeting (ASM) was held on Sunday 17 October and Monday…
Expanding Our Horizons – ANZUP ASM 2016
ANZUP ASM Review Ian Vela It was my pleasure and honor to act as the…